Markets:

Overview

News

Currencies

International

Treasuries

Novartis AG Common Stock (NY:NVS)

160.06 +1.86 (+1.18%)

Official Closing Price Updated: 4:10 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Novartis AG Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex

May 26, 2023

Smokeless Tobacco TreatmentÂ Comprehensive Study by Type (Keratosis Treatment, Addiction Treatment, Disease Treatment), Application (Hospitals & Clinics, Academic & Research Organizations, Pharmacies),...

Via SBWire

The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

May 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END

Via FinancialNewsMedia

Novartis AG (NYSE: NVS) Records 52-Week High Thursday Morning

April 06, 2023

Via Investor Brand Network

Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market

May 18, 2023

Big pharma stocks Novartis, Eli Lilly, Merck, and Novo Nordisk are outperforming the market, driven by successful drugs and strong earnings growth.

Via MarketBeat

Topics Economy

Oral Cancer Treatment Market Projected to Show Strong Growth : Bristol-Myers Squibb, Qilu Pharmaceutical, Novartis

May 15, 2023

Get Oral Cancer Treatment Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.

Via SBWire

AI for Pharma and Biotech Market Giants Spending Is Going to Boom : PFIZER, Abbott, SANOFI, Atomwise

May 09, 2023

Stay up-to-date with AI for Pharma and Biotech Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Topics Artificial Intelligence

R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments

May 02, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END

Via FinancialNewsMedia

Why Legend Biotech Stock Is Having Its Best Month Yet

April 25, 2023

With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high.

Via MarketBeat

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Presents Innovative Pipeline of Nanosized Antibody Treatments at Bio-Europe Spring Conference in Switzerland

April 18, 2023

Via Investor Brand Network

Epic Growth Story Predicted for Pharmaceutical Drug Delivery Market's Future: Johnson & Johnson, Novartis International, Merck

April 12, 2023

Stay up-to-date with Pharmaceutical Drug Delivery Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher

April 12, 2023

Tilray Brands moves lower on mixed results, but the bottom may be in, with positive FCF expected this quarter. The long-term catalyst is US legalization.

Via MarketBeat

Topics Cannabis

Pediatric Drugs Market Giants Spending Is Going to Boom : Pfizer, Bayer, Abbott Laboratories, Merck

April 10, 2023

NJ New Jersey, USA -- (SBWIRE) -- 04/10/2023 -- Latest Study on Industrial Growth of Pediatric Drugs Market 2022-2027. A detailed study accumulated to offer Latest insights about acute features of the...

Via SBWire

Novartis Shares Leap On Positive Clinical Trial Data

April 10, 2023

Swiss pharmaceutical giant Novartis leaped 5.11% in the past week following news that its Kisqali breast-cancer treatment cut the probability of relapse.

Via MarketBeat

New research project aims to set standardized approach to lipoprotein(a) management

March 24, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb

March 14, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 14, 2023 – USA News Group – Optimism is on the rise as the American Cancer Society is reporting that the five-year survival...

Via FinancialNewsMedia

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?

March 08, 2023

By David Willey, Benzinga

Via TheNewswire.com

Topics Economy

Lupus Therapeutics Market Is on the Verge of Crossing at High CAGR of 9% in 2022-2029

February 21, 2023

The global lupus therapeutics market is expected to reach a CAGR of 9% during the forecast period (2022-2029).

Via SBWire

Bladder Prolapse (Cystocele) Market to Touch at High CAGR of 8.3% by 2022-2029

February 20, 2023

Bladder Prolapse (cystocele) Market is expected to grow at a CAGR of 8.3 % during the forecast period (2022-2029).

Via SBWire

Choroidal Neovascularization Market Share Size Trends Overview Analysis 2022-2029

February 16, 2023

Global Choroidal Neovascularization Market to Witness Huge Growth by Key Players: Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann –La Roche AG,MaaT Pharma Novartis AG, Pfizer...

Via SBWire

Occupational Medicines Market Is Expected to Reach at High CAGR of 5.4% by 2022-2029

February 16, 2023

Occupational medicines market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5.4 % during the forecast period (2022-2029).

Via SBWire

Water for Injection Market Trends Outlook Demand 2023 -2030

February 13, 2023

Global Water for Injection Market to Witness Huge Growth by Key Players: Abbott Laboratories, AdvaCare Pharma, B. Braun SE, FUJIFILM Holdings Corp., GlaxoSmithKline Plc, Merit Healthcare International...

Via SBWire

Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?

February 10, 2023

Enterprise software maker Snowflake notched a three-month gain of 28.85%, far outpacing the S&P 500’s return of 9.32%. Analysts expect the price to rise 19%.

Via MarketBeat

Topics Stocks

Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030

February 09, 2023

The Europe liver cancer therapeutics size was valued at US$ 384 million in 2022 and is estimated to reach US$ 627 million by 2030, growing at a CAGR of 8.95% during the forecast period (2023-2030)

Via SBWire

Active Pharmaceutical Ingredients Market May Set Epic Growth Story : Pfizer, Novartis, Sanofi

February 07, 2023

Stay up-to-date with Active Pharmaceutical Ingredients Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Topics Death

Liposome Drug Delivery Market 2023 in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2029

February 02, 2023

Liposome Drug Delivery Market Size, Share and Forecast 2023-2029 Key Players are – Ipsen Pharma, Celsion Corp, Gilead Sciences, Astellas Pharma, Johnson & Johnson, Luye Pharma Group, Novartis AG

Via SBWire

Shigella Vaccines Market: Study Navigating the Future Growth Outlook

February 02, 2023

Get Shigella Vaccines Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.

Via SBWire

Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium

February 01, 2023

SAN DIEGO, February 1, 2023 (Newswire.com) - On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium,...

Via Newswire.com

Envision Pharma Group Hires Leading Industry Executives Dominic Marasco and Gregory Carpenter to Lead Further Expansion of the Business and Support Growing Customer Demand

January 31, 2023

PHILADELPHIA, January 31, 2023 (Newswire.com) - Envision Pharma Group (Envision) today announced the appointment of two senior executives while further expanding its global focus on M&A,...

Via Newswire.com

Pliant Therapeutics Gaps 34% Higher: More Upside To Come?

January 25, 2023

Pliant Therapeutics zoomed 34% higher and added to that gain in the next session.This followed good news about clinical trials for a lung-condition treatment.

Via MarketBeat

National Advertising Division Finds Novartis Breast Cancer Drug Claim Supported in Physician-Directed Messaging, But Not in Ads to Consumers

January 19, 2023

Via iCrowdNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novartis AG Common Stock (NY:NVS)

Press Releases about Novartis AG Common Stock

Starting at $3.75/week.

Subscribe Today